Ely, ABloom, KMaepa, M.BMahlangu, J.NPepper, M.SArbuthnot, P2024-10-042024-10-042019-09-10Ely A , Bloom K, Maepa MB, Mahlangu JN, Pepper MS, Arbuthnot P. Gene and cell therapy in South Africa: Current status and future prospects. South African Medical Journal. 2019 Sep;109(8b):12-16. doi: 10.7196/SAMJ.2019.v109i8b.1381910.7196/SAMJ.2019.v109i8b.1381910.7196/SAMJ.2019.v109i8b.13819http://www.samj.org.za/index.php/samj/article/view/12706https://hdl.handle.net/11288/597709South Africa has a high disease burden resulting from communicable and non-communicable diseases. Current therapeutic interventions rarely result in a cure and the associated lifelong treatment places a considerable strain on an overburdened health sector. Gene and cell therapies present novel alternatives to disease management, offering the promise of a single treatment and a lifelong cure. Although challenges remain, investment in the field has started to bear fruit, with a number of gene and cell therapeutics reaching the market in the past decade. To take full advantage of these developments, it is important that a proactive approach to nurturing appropriate human and material resources is adopted in the country.enAttribution 3.0 United Stateshttp://creativecommons.org/licenses/by/3.0/us/Gene and cell therapySouth AfricaGeneticsTherapeutic interventionsArticleSouth African Medical Journal